Recent Analysts’ Ratings Updates for Stryker (SYK)

Several analysts have recently updated their ratings and price targets for Stryker (NYSE: SYK):

• 7/9/2026 – Stryker was given a new $370.00 price target by Argus.
• 7/8/2026 – Stryker is now covered by BMO Capital Markets. They set an “outperform” rating and a $369.00 price target on the stock.
• 7/8/2026 – Stryker was upgraded by BMO Capital Markets to “strong-buy”.
• 7/6/2026 – Stryker was given a new $350.00 price target by Evercore Inc.
• 6/5/2026 – Stryker had its price target lowered by Leerink Partners from $410.00 to $407.00. They now have an “outperform” rating on the stock.
• 5/16/2026 – Stryker was downgraded by Wall Street Zen from “buy” to “hold”.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio (DPR) is 40.74%.

Insider Activity at Stryker

In other news, VP M Kathryn Fink sold 3,500 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $283.45, for a total value of $992,075.00. Following the sale, the vice president owned 177 shares of the company’s stock, valued at approximately $50,170.65. This represents a 95.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Ronda E. Stryker sold 310,000 shares of the stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the sale, the director owned 1,924,880 shares of the company’s stock, valued at $601,005,282.40. This trade represents a 13.87% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 323,264 shares of company stock valued at $100,659,489 in the last 90 days. 4.60% of the stock is owned by corporate insiders.

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.